Online Trial Tracker - Larvol Sigma

Sarcoma

Imlygic (talimogene laherparepvec)

Phase 1

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 1

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Imlygic (talimogene laherparepvec) / Amgen

NCT02890368: Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

	For advanced relapsed/refractory hematologic malignancies
	Jan 2020 - Jan 2020: For advanced relapsed/refractory hematologic malignancies
	Oct 2019 - Dec 2019 : For CTCL patients on continuation therapy
	Updated data for CTCL at ASH 2018 [screenshot]
	Dec 2018 - Dec 2018: Updated data for CTCL at ASH 2018 [screenshot]
	Interim results for in relapsed/refractory mycosis fungoides and Sézary syndrome
	Dec 2018 - Dec 2018: Interim results for in relapsed/refractory mycosis fungoides and Sézary syndrome
	Data presentation in r/r mycosis fungoides and Sezary syndrome at EORTC CLTF 2018 [screenshot]
	Sep 2018 - Sep 2018: Data presentation in r/r mycosis fungoides and Sezary syndrome at EORTC CLTF 2018 [screenshot]
	Safety and efficacy results at ASH 2017 [screenshot]
	Dec 2017 - Dec 2017: Safety and efficacy results at ASH 2017 [screenshot]
	From expansion cohorts of P1 trial for hematological malignancies, solid tumors and mycosis fungoides at SITC 2017 [screenshot]
	Nov 2017 - Nov 2017: From expansion cohorts of P1 trial for hematological malignancies, solid tumors and mycosis fungoides at SITC 2017 [screenshot]
More

Terminated

TTI-621 Monotherapy, SIRPα-IgG1 Fc, TTI-621 + PD-1/PD-L1 Inhibitor, SIRPα-IgG1 Fc + PD-1/PD-L1 Inhibitor, TTI-621 + pegylated interferon-α2a, SIRPα-IgG1 Fc + pegylated interferon-α2a, TTI-621 + T-Vec, SIRPα-IgG1 Fc + talimogene laherparepvec, TTI-621 + radiation, SIRPα-IgG1 Fc + radiation

Pfizer

Solid Tumors, Mycosis Fungoides, Melanoma, Merkel-cell Carcinoma, Squamous Cell Carcinoma, Breast Carcinoma, Human Papillomavirus-Related Malignant Neoplasm, Soft Tissue Sarcoma

03/20

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites